Non-HLA Antibodies and the Risk of Antibody-mediated Rejection without Donor-specific Anti-HLA Antibodies After Lung Transplantation.

Autor: Comins-Boo A; Immunology Department, Immunopathology Group, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain., Mora-Fernández VM; Neumology Department, Immunopathology Group, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain., Padrón-Aunceame P; Immunology Department, Immunopathology Group, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain., Toriello-Suárez M; Immunology Department, Immunopathology Group, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain., González-López E; Immunology Department, Immunopathology Group, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain., Roa-Bautista A; Immunology Department, Immunopathology Group, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain., Castro-Hernández C; Immunology Department, Immunopathology Group, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain., Iturbe-Fernández D; Neumology Department, Immunopathology Group, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain., Cifrián José M; Neumology Department, Immunopathology Group, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain., López-Hoyos M; Immunology Department, Immunopathology Group, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain., San Segundo D; Immunology Department, Immunopathology Group, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain. Electronic address: david.sansegundo@scsalud.es.

Publikováno v: Transplantation proceedings [Transplant Proc] 2025 Jan 02. Date of Electronic Publication: 2025 Jan 02.